Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Riociguat: a novel new drug for treatment of pulmonary hypertension.
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Riociguat: a novel new drug for treatment of pulmonary hypertension.
Riociguat: a novel new drug for treatment of pulmonary hypertension. Pharmacotherapy. 2015 May; 35(5):502-19.
View in:
PubMed
subject areas
Clinical Trials, Phase III as Topic
Guanylate Cyclase
Humans
Hypertension, Pulmonary
Pyrazoles
Pyrimidines
Receptors, Cytoplasmic and Nuclear
Soluble Guanylyl Cyclase
authors with profiles
Richard W. Rissmiller
Wendy Moore Bullington